Albatira, Baby Boy T.
HRN: 21-26-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/23/2022
05/29/2022
IV
54mg
Q24hrs
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes